DEXTROSE 5 %

Negara: Israel

Bahasa: Inggris

Sumber: Ministry of Health

Bahan aktif:

GLUCOSE AS MONOHYDRATE

Tersedia dari:

LAPIDOT MEDICAL IMPORT AND MARKETING LTD

Kode ATC:

B05CX01

Bentuk farmasi:

SOLUTION FOR INFUSION

Komposisi:

GLUCOSE AS MONOHYDRATE 5 G / 100 ML

Rute administrasi :

I.V

Jenis Resep:

Required

Diproduksi oleh:

B.BRAUN MELSUNGEN AG., GERMANY

Kelompok Terapi:

GLUCOSE

Area terapi:

GLUCOSE

Indikasi Terapi:

Vehicle solution for supplementary medication. Energy supply, hypertonic dehydration.

Tanggal Otorisasi:

2023-09-30

Karakteristik produk

SUMMARY OF PRODUCT CHARACTERISTICS
B. Braun Melsungen AG · 34209 Melsungen · Germany
_The format of this leaflet was determined by the Ministry _
_of Health and its content was checked and approved in _
_september 2008_
1 NAME OF THE MEDICINAL PRODUCT
Dextrose 5%
schwarz
Dokument = 148 x 210 mm (A5)
2 Seiten
Dextrose 5%
4/12606529/0911 – IL
Standort MEG
Lätus
G 081486
B|BRAUN
4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Monitoring of blood glucose, fluid balance serum electro-
lytes, acid-base balance and serum potassium is necessary
during administration of Glucose B. Braun 50 mg/ml Solu-
tion for Infusion.
In patients with disturbed glucose metabolism, as present
e.g. in postoperative or posttraumatic conditions, Dextrose
5% must be administered with care, i.e. under blood glucose
monitoring, and dosage must be adapted in order to prevent
physiological stress. Dextrose 5% should only be adminis-
tered with caution in patients with diabetes mellitus.
Glucose infusions should not be administered through the
same infusion equipment, simultaneously with, before, or
after administration of blood, because of the possibility of
pseudo-agglutination.
Hyperglycemia and glycosuria may be functions of rate of
administration or metabolic insufficiency. To minimize these
conditions, slow the infusion rate, monitor blood and urine
glucose; if necessary, administer insulin. When concen-
trated dextrose infusion is abruptly withdrawn, administer
5% dextrose to avoid hypoglycemic reactions. Administer
so that extravasation does not occur. If thrombosis occurs
during administration, stop infusion and correct.
Clinical supervision should include regular checks of blood
glucose level, serum electrolytes and water balance. Electro-
lytes are to be supplemented as required.
Hypokalemia: Excessive administration of potassium free
solutions may result in significant hypokalemia. Add potas-
sium to dextrose solutions and administer to fasting pa-
tients with good renal function, especially those on digitalis
therapy.
Vitamin B com